Cancer Mutations Turned into Weapons Against Tumors via New Immunotherapy

Researchers have developed a novel method to combat drug-resistant cancers by leveraging the mutations that enable tumors to evade treatment. These mutations generate unique protein fragments called neo-antigens, which can be targeted by the immune system. A computational tool, SpotNeoMet, identifies common therapy-resistance mutations across patients, paving the way for broader immunotherapy applications.

Read the full story on Quick Digest